Continued Supply. If the Landlord continues to supply the Tenant with Tied Drinks notwithstanding any proceedings commenced by the Landlord against the Tenant for any breach by the Tenant of its obligations under this lease, such continuation of supply shall not:
Continued Supply. In the event that (a) Aspect makes an assignment for the benefit of creditors, or a receiver, trustee in bankruptcy or similar officer is appointed to take charge of any or all of Aspect's property, or Aspect files a voluntary petition under federal bankruptcy laws or similar state statutes or such a petition is filed against Aspect and is not dismissed within sixty (60) days, and (b) Aspect fails to deliver Aspect Products ordered by HP under this Agreement within [**] of the delivery date specified on a purchase order complying with Section 4 and accepted by Aspect in accordance with Section 4, upon request of HP, Aspect shall grant to HP, a nonexclusive license to use the Manufacturing Materials to make and have made the Aspect Products for use in the HP BIS System, until [**] after Aspect is ready and able to deliver Aspect Products to HP under the terms of this Agreement and has notified HP thereof. This includes a non-exclusive license to use any tools, design documentation, or any other manufacturing materials which may be necessary. The manufacturing materials supplied by Aspect shall include a list of the Aspect suppliers of parts for Aspect Products. Upon exercise by HP of the manufacturing license set forth above, HP shall pay Aspect a "Manufacturing License Fee" equal to the royalty specified on Exhibit A (Aspect's Products and Purchase Prices).
Continued Supply. 21.1 The Seller undertakes to supply the Items, including spare parts and repair services for the Items to CMC and CMC’s for so long as any aircraft fitted with the Items is in service anywhere in the world, at fair and reasonable prices to be agreed upon by the Parties at the time of such request.
Continued Supply. Except in the event of a Required Change or other circumstances requiring the prompt implementation of a proposed Material Change (including where prescribed by law or the requirements of an applicable Regulatory Authority), Miltenyi shall continue to supply Miltenyi Product without the proposed Material Change for [***], using Commercially Reasonable Efforts, to make all appropriate filings and obtain any required amendment or modification of existing regulatory approvals for Autolus Product (unless otherwise agreed, such period not to exceed [***] from the proposed date of implementation of the Material Change as provided in Miltenyi’s change notification pursuant to Section [***].[***].), subject to the Parties reaching agreement, except with respect to any Miltenyi-Requested Change, as to the [***] necessitated by any such continued supply of unchanged Miltenyi Product during such period. If the continued supply of unchanged Miltenyi Product is reasonably estimated by the Parties to exceed a period of [***] from the implementation date of the Material Change notified pursuant to Section [***].[***]., then the Party shall promptly meet to discuss in good faith how to remedy the situation. Notwithstanding the preceding provisions of this subsection (g), in the event that Autolus reasonably determines to reject a proposed Material Change (including a Miltenyi-Requested Change), Miltenyi agrees to continue to supply the applicable Miltenyi Product without such change after expiry of the said [***] period and during the Term of this Agreement or until Autolus has secured an alternate source of supply from a Third Party manufacturer; provided, however, that as a condition precedent to Miltenyi’s continuing obligation to supply unchanged Miltenyi Product after expiry of the said [***] period, this Agreement shall have first been amended, by mutual written agreement between the Parties, as appropriate to reflect the change in circumstances contemplated by this Section [***]. and any [***] (if any) resulting from the manufacture of unchanged Miltenyi Product solely for Autolus, including any applicable adjustments to [***] or other relevant issues. For clarity, in no event shall Miltenyi be required to manufacture, supply or sell a Miltenyi Product to which a Required Change is applicable. EXHIBIT 10.2 ***Text Omitted and Filed Separately Confidential Treatment Requested Under 17 C.F.R. §§ 200.80(B)(4) and 230.406
Continued Supply. If AEVI has any inventory of any Licensed Products suitable for use in clinical trials, AEVI will offer to sell such Licensed Products to KKC at (***) (but KKC will be under no obligation to purchase the foregoing inventory of Licensed Products unless it agrees to do so in writing at such time); provided, however, that, in the event of a termination pursuant to Section 10.3.3, (***). If AEVI has the capability in place as of the effective date of such termination to commercially Manufacture and supply to KKC all or part of KKC’s requirements of the applicable Licensed Products, if KKC so elects in its sole discretion, AEVI will use Commercially Reasonable Efforts to supply to KKC (***) as much of KKC’s requirements of such Licensed Products (and to develop a reasonable inventory level) during such period, (***) for such Licensed Products, under terms and conditions as may be mutually agreed between the Parties. If KKC, despite its best efforts, is unable to Manufacture, or to secure a supply of, such Licensed Products in an amount sufficient to meet its requirements (***), AEVI will continue to supply such Licensed Products to KKC to the extent necessary to meet KKC’s requirements, so long as KKC continues to use its best efforts to develop the capabilities necessary to Manufacture such Licensed Products and/or to secure a supply of such Licensed Products.
Continued Supply. Unless you contact us to cancel the Service when your Term ends, we will continue to provide the Service on a monthly basis and you agree to continue paying the charges.
Continued Supply. The Terminating Party will transfer to the Continuing Party all quantities of the Terminated Product in its possession for which the manufacturing costs were shared by the Parties under Article 7 (Profit/Expense Sharing). In addition, the Terminating Party will, at the Continuing Party’s cost and expense, reasonably cooperate, as requested by the Continuing Party, to ensure uninterrupted supply of the Terminated Product. To the extent the Terminating Party was responsible for manufacturing the Terminated Product as of the Termination Effective Date, then the Terminating Party will continue to provide for manufacturing of such Terminated Product for the Continuing Party, at the fully-burdened manufacturing cost therefore, from the date of notice of such termination with respect to such Terminated Product, until the sooner to occur of such time as the Continuing Party is able, using Commercially Reasonable Efforts to do so, to secure an acceptable alternative manufacturing source from which sufficient quantities of Terminated Product may be procured or [*] months from the Termination Effective Date.
Continued Supply. The Parties shall use their commercially reasonable efforts to complete the transition of the Transitioned Manufacturing as soon as practicable, as applicable.
Continued Supply. If medically appropriate, at the time the Protocol closes early to accrual, Study Drugs shall continue to be supplied in accordance with this Article V to Subjects receiving the Study Drugs, until completion of treatment as prescribed in the Protocol.
Continued Supply. In the event this Article 8 (TRANSFER OF MANUFACTURING) applies due to Section 8.1 (a), (e) or (f) above, at Replidyne’s election and request, the Supplier shall continue to supply such quantities of the Drug Substance as Replidyne may request in an uninterrupted manner (or, in the case of Section 8.1(b), (c) or (d) above, use commercially reasonable efforts to do so), until such time as Replidyne’s or the Manufacturing Designee’s facility is certified by the applicable Regulatory Authorities and able to meet Replidyne’s requirements for the Drug Substance, provided, however, that such term shall not exceed two (2) years from the date of Replidyne’s notice invoking the provisions of Section 8.1 (
